Passer au contenu principal

Maladie de Wilson

La maladie de Wilson est un trouble génétique dans lequel le cuivre s'accumule dans le corps, principalement dans le foie et le cerveau. Sans traitement, l'accumulation de cuivre peut provoquer des symptômes graves. Le traitement consiste en des médicaments pour éliminer l'excès de cuivre et/ou pour prévenir une nouvelle accumulation de cuivre.

En un coup d'œil

  • Wilson's disease is a rare inherited condition where too much copper builds up in the body.

  • Elle est causée par un gène défectueux qui empêche le corps de se débarrasser de l'excès de cuivre.

  • Le cuivre s'accumule principalement dans le foie, le cerveau et la couche frontale de l'œil.

  • Les symptômes apparaissent généralement entre 6 et 20 ans, affectant le foie et le cerveau.

  • Diagnosis involves blood and urine tests, eye examination, or a liver biopsy.

  • Le traitement comprend des médicaments pour éliminer le cuivre ou bloquer son absorption, et est à vie.

  • La maladie de Wilson non traitée peut être fatale, généralement avant l'âge de 40 ans.

What is Wilson's disease?

Wilson's disease is a condition where too much copper builds up in the body. It is a rare inherited disorder that affects about 1 in 30,000 people. It is named after Dr Samuel Wilson who first described the disorder in 1912.

People who inherit the genetic fault in Wilson's disease are not able to get rid of copper from their body. Copper is a trace metal which is in many foods. Tiny amounts of copper are needed to remain healthy. Normally, the body gets rid of any excess copper. People with Wilson's disease cannot get rid of this excess copper and so it builds up in the body, mainly in the liver, the brain, the layer at the front of the eye (called the cornea) and the kidneys.

Too much copper in the liver cells (the hepatocytes) is harmful and leads to liver damage. Damage to brain tissue mainly occurs in an area called the lenticular nucleus. Hence, Wilson's disease is sometimes also called hepatolenticular degeneration.

What causes Wilson's disease?

In Wilson's disease, a particular gene on chromosome 13 does not work. The gene is called ATP7B. This gene normally controls the way the liver cells get rid of excess copper. Normally, the liver cells pass out excess copper into the bile. If this process does not work then the copper builds up in liver cells. When the copper storage capacity of the liver cells is exhausted, the copper spills into the bloodstream and deposits copper in other parts of the body, mainly the brain.

How is Wilson's disease inherited?

Wilson's disease is an autosomal recessive disorder. This means that, in order to develop Wilson's disease, two abnormal ATP7B genes must be inherited - one from each parent.

Wilson's inheritance

Wilson's inheritance

People who inherit only one copy of the abnormal gene are called carriers. Carriers do not have the disorder, as they have one normal gene which is enough to control the function of copper in the body. However, carriers can pass the abnormal gene on to their children.

How common is Wilson's disease?

About 1 in 100 people are carriers of the ATP7B gene. When two people who carry the abnormal gene have a child, there is a:

  • 1 in 4 chance that the child will have Wilson's disease (by inheriting the abnormal ATP7B gene from both parents).

  • 2 in 4 chance that the child will not have Wilson's disease, but will be a carrier (by inheriting the abnormal ATP7B gene from one parent but the normal gene form the other parent).

  • 1 in 4 chance that the child will not have Wilson's disease, and will not be a carrier (by inheriting the normal gene from both parents).

Wilson's disease symptoms

Although the genetic defect is present at birth, it takes several years for copper to build up to a level where it starts to cause damage. Symptoms typically start to develop between the ages of 6 and 20, most commonly in the teenage years, but some people don't start to develop symptoms until middle age.

Problèmes hépatiques

Symptoms of liver problems often develop first. The toxic effect on the liver cells can cause inflammation of the liver (hepatitis) which may cause:

  • Yellowing of the skin or the whites of the eyes (jaundice).

  • Douleur au ventre (abdominale).

  • Episodes of being sick (vomiting).

If left untreated, damage to liver cells causes scarring of the liver (cirrhosis). Eventually, severe cirrhosis and liver failure develop in untreated cases, causing severe problems.

(Remarque: there are various causes of cirrhosis. Wilson's disease is a very rare cause of cirrhosis.)

Brain problems

As copper deposits in the brain it can cause various symptoms.

Physical symptoms, including:

  • Tremor in the arms.

  • Slowness of movement.

  • Difficulty with speech.

  • Writing problems.

  • Difficulté à avaler.

  • An unsteady walk.

  • Maux de tête.

  • Fits (seizures).

Psychological symptoms, including:

  • Dépression.

  • Mood swings

  • Inability to concentrate.

  • A personality change leading to argumentative and emotional behaviour.

Severe problems. If left untreated, the accumulation of copper in the brain can lead to:

  • Severe muscular weakness.

  • Severe rigidity.

  • Dementia.

Wilson's disease eyes

Copper may build up in the layer at the front of the eye (called the cornea). This causes a characteristic feature called Kayser-Fleischer rings - a brownish pigmentation of the cornea.

Kayser-Fleischer ring

Kayser-Fleischer ring

Other Wilson's disease features

Other features that may develop include:

  • Anémie.

  • Kidney damage.

  • Problèmes cardiaques.

  • Inflammation of the pancreas (pancreatitis).

  • Problèmes menstruels.

  • Repeated miscarriage in women.

  • Premature 'thinning' of the bones (osteoporosis).

How is Wilson's disease diagnosed?

If Wilson's disease is suspected, it can be diagnosed by various tests:

  • Un test sanguin to measure caeruloplasmin. This is a protein that binds copper in the bloodstream. The level is low in nearly all people with Wilson's disease.

  • Other blood tests may also be performed. These may be done to measure the copper levels and to test kidney and liver function.

  • A specialist may arrange a urine test to measure the amount of copper in the urine over a 24-hour period. The amount is typically higher than normal.

  • An examination of the layer at the front of the eye (called the cornea) by an optician (optometrist) or an eye specialist may show the Kayser-Fleischer rings if they have developed. (They are not present in all cases.)

  • A small sample (biopsy) of the liver may be taken to look at under the microscope. This can show the excess copper in the liver and the extent of any scarring of the liver (cirrhosis). See the separate leaflet called Liver biopsy for more details.

  • Other tests may also be advised - for example, a imagerie par résonance magnétique (IRM).

If Wilson's disease is confirmed then siblings should be checked to see if they have the condition. Brothers and sisters of a person with Wilson's disease have a 1 in 4 chance of also having the condition.

Wilson's disease treatment

It is essential to treat Wilson's disease as, without treatment, it can be fatal. The earlier treatment is started, the better the chance of preventing long-term permanent damage to the liver or brain. There is no cure for Wilson's disease but treatment reduces the risks of complications.

  • Pénicillamine is a medicine called a chelating agent and is used to remove copper from the body. The penicillamine causes the excess copper from the body to be passed out in the urine. The dose may be reduced to a maintenance dose after about a year when the initial build-up of copper has been cleared. Unfortunately, the symptoms of Wilson's disease can deteriorate as a side effect of the medication.

  • Trientine is an alternative to penicillamine. It too is a chelating agent and removes copper from the body. It has slightly fewer side effects.

  • Zinc is an option in certain circumstances. Zinc works by blocking the gut from absorbing copper from food. Therefore, it does not clear excess copper from the body, but prevents any further build-up of copper. Zinc is much less likely than penicillamine or trientine to cause side-effects. It may be an option for people who are diagnosed at the very early stages of the disease and have no symptoms. Also, a switch to zinc may be an option for people who have been initially treated with penicillamine or trientine once the initial build-up of copper has been cleared from the body. Zinc may also be taken by pregnant women.

Note: treatment is needed for life. First, it is used to clear the excess copper and then to prevent future accumulation of copper. Failure to take medication can lead to a return to a build-up of copper, which can be serious - even fatal.

For the few people who do not respond to treatment with medication, or are diagnosed in the late stage of the disease with severe scarring of the liver (cirrhosis) or liver failure, a liver transplant may be an option. This can be life-saving. The long-term outlook after a liver transplant is usually very good.

Régime alimentaire

Foods with a high concentration of copper generally should be avoided, at least in the first year of treatment when the excess copper is being cleared from the body. These include liver, chocolate, nuts, mushrooms and shellfish, especially lobster.

Complications of Wilson's disease

  • If treatment is begun in the early stages of the disease, it usually works very well. A normal length and quality of life can be expected.

  • However, without any treatment, Wilson's disease is usually fatal - typically before the age of 40.

  • If symptoms have developed before treatment has started, some of the symptoms improve with treatment but some may remain permanently. For example, some of the brain symptoms are permanent once they develop. A specialist will be able advise about which symptoms may go and which may be permanent, once treatment begins.

Sélections des patients pour Conditions génétiques

Questions fréquemment posées

Si je suis porteur du gène de la maladie de Wilson, puis-je encore le transmettre même si je n'ai pas la maladie ?

Oui, si vous héritez d'une seule copie du gène anormal, vous êtes considéré comme porteur. Les porteurs ne développent pas eux-mêmes la maladie de Wilson car ils ont un gène normal qui est suffisant pour contrôler la fonction du cuivre. Cependant, les porteurs peuvent transmettre le gène anormal à leurs enfants.

Quelle est la probabilité qu'un enfant ait la maladie de Wilson si les deux parents sont porteurs ?

Si les deux parents sont porteurs du gène ATP7B anormal, il y a une chance sur 4 que leur enfant hérite de deux gènes anormaux et développe donc la maladie de Wilson. Il y a également une chance sur 2 que l'enfant soit porteur et une chance sur 4 que l'enfant n'ait pas la maladie de Wilson et ne soit pas porteur.

Que se passe-t-il si le traitement de la maladie de Wilson n'est pas suivi de manière cohérente ?

Le traitement de la maladie de Wilson est nécessaire à vie. Initialement, il élimine l'excès de cuivre, puis il empêche l'accumulation future. Ne pas prendre le médicament peut entraîner un retour de l'accumulation de cuivre, ce qui peut être grave et même fatal.

Quels aliments spécifiques devrais-je limiter ou éviter si j'ai la maladie de Wilson ?

Les aliments avec une forte concentration de cuivre devraient généralement être évités, surtout pendant la première année de traitement lorsque l'excès de cuivre est éliminé du corps. Ceux-ci incluent le foie, le chocolat, les noix, les champignons et les fruits de mer, en particulier le homard.

Quel est le pronostic à long terme pour une personne ayant subi une greffe de foie en raison de la maladie de Wilson ?

Pour les quelques personnes qui ne répondent pas au traitement médicamenteux ou qui sont diagnostiquées tardivement avec des lésions hépatiques sévères ou une insuffisance hépatique, une greffe du foie peut être une option salvatrice. Les perspectives à long terme après une greffe du foie sont généralement très bonnes.

Lectures complémentaires et références

À propos de l'auteurVoir la biographie complète

Image de l'auteur

Dr Philippa Vincent, MRCGP

Médecin généraliste, Auteur médical

MB BS, Bsc, MRCGP (2000), DCH, DFSRH, DRCOG

Dr Philippa Vincent est un médecin généraliste du NHS travaillant dans le nord de Londres.

À propos du critiqueVoir la biographie complète

Image de l'auteur

Dr Doug McKechnie, MRCGP

Rédacteur Médical

MA, MBBS, MSc, DRCOG, MRCP(UK), MRCGP(2021), FHEA

Le Dr Doug McKechnie est un médecin généraliste du NHS travaillant à Londres. Il travaille à plein temps en clinique et est également le chef adjoint du module de Pratique Clinique et Professionnelle à l'École de Médecine de l'University College London.

Historique de l'article

Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.

vérificateur d'éligibilité à la grippe

Demandez, partagez, connectez-vous.

Parcourez les discussions, posez des questions et partagez vos expériences sur des centaines de sujets de santé.

vérificateur de symptômes

Vous ne vous sentez pas bien ?

Évaluez vos symptômes en ligne gratuitement

Inscrivez-vous à la newsletter Patient

Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.

Veuillez entrer une adresse e-mail valide

En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.